Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumour hypoxia in head and neck squamous cell carcinoma (HNSCC) impacts outcomes. New preclinical models show promise for testing hypoxia-targeting therapies, but additional biomarkers are needed to predict drug sensitivity.
Area Of Science
- Oncology
- Cancer Biology
- Preclinical Research
Background
- Tumour hypoxia is linked to poor patient outcomes, especially in head and neck squamous cell carcinoma (HNSCC).
- Effective hypoxia-targeting therapies require accurate preclinical models and selection biomarkers.
- Current models may not fully recapitulate clinical HNSCC hypoxia.
Purpose Of The Study
- To establish and characterize patient-derived xenograft (PDX) and cell line-derived xenograft (CDX) models of HNSCC.
- To evaluate the fidelity of these models in representing clinical HNSCC gene expression, hypoxia, and proliferation.
- To assess the sensitivity of these models to hypoxia-activated prodrugs (HAPs).
Main Methods
- Established 20 HNSCC PDX and CDX models.
- Characterized models for gene expression, hypoxia (gene signatures, pimonidazole IHC), and proliferation.
- Evaluated HAP sensitivity using tumour growth inhibition and ex vivo clonogenic assays.
Main Results
- PDX models demonstrated higher gene expression fidelity to clinical HNSCC than cell lines.
- PDX models were significantly more hypoxic than CDX models, mirroring clinical HNSCC hypoxia.
- Neither hypoxia nor proliferation status alone predicted HAP sensitivity across models.
Conclusions
- Developed clinically relevant HNSCC preclinical models for evaluating hypoxia-targeting therapies.
- PDX models offer superior fidelity for hypoxia research compared to CDX models.
- Additional biomarkers beyond hypoxia are necessary for predicting HAP drug sensitivity in HNSCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
